MAPT and Alzheimer disease: Interestingly, Vps35 gene delivery into the central nervous system in mice significantly improves synaptic pathology and neuroinflammation, attenuating AD-induced alterations in spatial learning and working memory, significantly reducing Aβ levels and deposition and tau phosphorylation [173].